Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Effect of Partially Hydrolyzed, Whey-based Infant Formulas on Growth and Tolerability in Healthy Term Infants: a Double-blind, Randomized, Controlled, Multi-arm Trial

NCT05868408 is registered in ClinicalTrials.gov with Société des Produits Nestlé (SPN) as lead sponsor.

NCT NCT05868408
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT05868408 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Effect of Partially Hydrolyzed, Whey-based Infant Formulas on Growth and Tolerability in Healthy Term Infants: a Double-blind, Randomized, Controlled, Multi-arm Trial
Lead sponsor
Société des Produits Nestlé (SPN)
Phase
Not applicable
Overall status
Recruiting
Start date
August 17, 2023
Completion date
June 30, 2028
Enrollment
234 (estimated)
Sites
5

Conditions

As the registry lists them; a condition with its own page is linked.

growth and development, infant development, infant formula, infant health, infant nutritional physiological phenomena